117 related articles for article (PubMed ID: 6793299)
1. Intracervical release of levonorgestrel for contraception.
Kurunmäki H; Toivonen J; Lähteenmäki P; Luukkainen T
Contraception; 1981 May; 23(5):473-85. PubMed ID: 6793299
[TBL] [Abstract][Full Text] [Related]
2. Levonorgestrel plasma concentrations and hormone profiles after insertion and after one year of treatment with a levonorgestrel-IUD.
Nilsson CG; Lähteenmäki P; Luukkainen T
Contraception; 1980 Mar; 21(3):225-33. PubMed ID: 6771090
[TBL] [Abstract][Full Text] [Related]
3. Plasma levonorgestrel levels and ovarian function during the use of a levonorgestrel-releasing intracervical contraceptive device.
Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T
Contraception; 1989 Feb; 39(2):195-204. PubMed ID: 2495893
[TBL] [Abstract][Full Text] [Related]
4. Patterns of ovulation and bleeding with a low levonorgestrel-releasing intrauterine device.
Nilsson CG; Lähteenmäki P; Luukkainen T
Contraception; 1980 Feb; 21(2):155-64. PubMed ID: 6768490
[TBL] [Abstract][Full Text] [Related]
5. Pituitary and ovarian function and clinical performance during the use of a levonorgestrel-releasing intracervical contraceptive device.
Kurunmäki H; Toivonen J; Lähteenmäki PL; Luukkainen T
Contraception; 1984 Jan; 29(1):31-43. PubMed ID: 6428806
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and pharmacodynamic investigations with vaginal devices releasing levonorgestrel at a constant, near zero order rate.
Landgren BM; Johannisson E; Masironi B; Diczfalusy E
Contraception; 1982 Dec; 26(6):567-85. PubMed ID: 6820337
[TBL] [Abstract][Full Text] [Related]
7. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
Pakarinen PI; Suvisaari J; Luukkainen T; Lähteenmäki P
Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585
[TBL] [Abstract][Full Text] [Related]
8. Clinical performance of a levonorgestrel-releasing intracervical contraceptive device during the first year of use.
Ratsula K
Contraception; 1987 Dec; 36(6):659-66. PubMed ID: 3128429
[TBL] [Abstract][Full Text] [Related]
9. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.
Xiao B; Zeng T; Wu S; Sun H; Xiao N
Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977
[TBL] [Abstract][Full Text] [Related]
10. A clinical pharmacological study of a new type of vaginal delivery system for levonorgestrel.
Landgren BM; Johannisson E; Xing S; Aedo AR; Diczfalusy E
Contraception; 1985 Dec; 32(6):581-601. PubMed ID: 3937664
[TBL] [Abstract][Full Text] [Related]
11. Hormonal consequences of missing the pill during the first two days of three consecutive artificial cycles.
Landgren BM; Diczfalusy E
Contraception; 1984 May; 29(5):437-46. PubMed ID: 6430642
[TBL] [Abstract][Full Text] [Related]
12. Clinical performance of a levonorgestrel-releasing intracervical contraceptive device during the first two years of use.
Ratsula K
Contraception; 1989 Feb; 39(2):187-93. PubMed ID: 2495892
[TBL] [Abstract][Full Text] [Related]
13. Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M
Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982
[TBL] [Abstract][Full Text] [Related]
14. Clinical and endocrinologic study of continuous levonorgestrel administration from subcutaneous solid polydimethylsiloxane rods.
Roy S; Stanczyk F; Mishell DR; Lumkin M; Gentzschein E
Contraception; 1980 Jun; 21(6):595-615. PubMed ID: 6775868
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and pharmacodynamic studies of vaginal rings releasing low-dose levonorgestrel.
Xiao BL; Zhang XL; Feng DD
Contraception; 1985 Nov; 32(5):455-71. PubMed ID: 3936678
[TBL] [Abstract][Full Text] [Related]
16. Plasma concentrations of levonorgestrel as a function of the release rate of levonorgestrel from medicated intra-uterine devices.
Nilsson CG; Lähteenmäki P; Robertson DN; Luukkainen T
Acta Endocrinol (Copenh); 1980 Mar; 93(3):380-4. PubMed ID: 7376797
[TBL] [Abstract][Full Text] [Related]
17. Bleeding and serum d-norgestrel, estradiol and progesterone patterns in women using d-norgestrel subdermal polysiloxane capsules for contraception.
Moore DE; Roy S; Stanczyk FZ; Mishell DR
Contraception; 1978 Apr; 17(4):315-28. PubMed ID: 648154
[TBL] [Abstract][Full Text] [Related]
18. Blood levels of levonorgestrel in women following vaginal placement of contraceptive pills.
Alvarez F; Faundes A; Johansson E; Coutinho E
Fertil Steril; 1983 Jul; 40(1):120-3. PubMed ID: 6407876
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamic effects of ethinyl estradiol in women using vaginal devices releasing small doses of levonorgestrel at a constant rate.
Toddyvalla V; Johannisson E; Landgren BM; Cekan SZ; Diczfalusy E
Contraception; 1983 Jul; 28(1):21-39. PubMed ID: 6414759
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and pharmacodynamic studies of levonorgestrel-releasing intrauterine device.
Xiao BL; Zhou LY; Zhang XL; Jia MC; Luukkainen T; Allonen H
Contraception; 1990 Apr; 41(4):353-62. PubMed ID: 2335100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
